Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCN-01 in advanced renal cell carcinoma
NCT00030888Phase 2Unknown
- Sponsor
- University of California, San Francisco
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 7-hydroxystaurosporine in renal cell carcinoma (RCC), sponsored by University of California, San Francisco. Primary endpoints: Time to objective progression and Objective Response Rate. Status: unknown.
02
Drugs
7-hydroxystaurosporine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00030888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030888.